Biotech faces brighter, if more complex future
Catapult CEO Chris Molloy reflects on the latest trends and debates from BIO 2017 The world’s biotech community came together at BIO in San Diego last week. And, above the usual clamour of countries competing to promote their sectors – and their national cultures and delicacies (the Czech Republic even had a folk singer in […]
Catapult open for business to support UK drug discovery
New £1m facilities at University of Warwick open to support collaborative drug discovery, announces CEO Chris Molloy I am five months into my job as Chief Executive of the Medicines Discovery Catapult and I am delighted to be able to say we are now well and truly open for business to support and promote innovative, […]
The Time is Now!
CEO Chris Molloy celebrates 100 days at the Medicines Discovery Catapult It is 100 days since I started as CEO of the Medicines Discovery Catapult. Every day since, engagement with the broad UK Medicines community has increased my certainty of being able to deliver unique help, enabling them to get better medicines to patients faster. By taking advantage […]